Hybridization Neutralizing Solution

<strong>Hybridization Neutralizing Solution </strong>_x000D_ <strong>Catalog number:</strong> B2016391_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 L_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> RT_x000D_ <strong>Keywords:</strong> Hybridization Neutralizing Solution_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Li Y, Liu P, Hao T, Liu S, Wang X, Xie Y, Xu K, Lei W, Zhang C, Han P, Li Y, Jin X, Huan Y, Lu Y, Zhang R, Li X, Zhao X, Xu K, Liao P, Lu X, Bi Y, Song H, Wu G, Zhu B, Gao GF. Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD Emerg Microbes Infect. 2023 Dec;12(2):2231573._x000D_ 2: Yanik S, Venkatesh V, Parker ML, Ramaswamy R, Diouf A, Sarkar D, Miura K, Long CA, Boulanger MJ, Srinivasan P. Structure guided mimicry of an essential P. falciparum receptor-ligand complex enhances cross neutralizing antibodies Nat Commun. 2023 Sep 21;14(1):5879._x000D_ 3: Martí D, Alemán C, Ainsley J, Ahumada O, Torras J. IgG1-b12-HIV-gp120 Interface in Solution: A Computational Study J Chem Inf Model. 2022 Jan 24;62(2):359-371._x000D_ 4: Costiniuk CT, Singer J, Lee T, Galipeau Y, McCluskie PS, Arnold C, Langlois MA, Needham J, Jenabian MA, Burchell AN, Samji H, Chambers C, Walmsley S, Ostrowski M, Kovacs C, Tan DHS, Harris M, Hull M, Brumme ZL, Lapointe HR, Brockman MA, Margolese S, Mandarino E, Samarani S, Vulesevic B, Lebouché B, Angel JB, Routy JP, Cooper CL, Anis AH; COVAXHIV Study Group. Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada AIDS. 2023 Oct 1;37(12):F25-F35._x000D_ 5: Rahman A, Roy KJ, Deb GK, Ha T, Rahman S, Aktar MK, Ali MI, Kafi MA, Choi JW. Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves Int J Mol Sci. 2023 Aug 23;24(17):13130._x000D_ 6: García-Vielma C, Cortés-Gutiérrez EI, Fernández JL, Dávila-Rodríguez MI, Gosálvez J. DBD-FISH Using Specific Chromosomal Region Probes for the Study of Cervical Carcinoma Progression Methods Mol Biol. 2024;2784:271-284._x000D_ 7: Bhandari A, Peng C, Dziedzic J, Anton L, Owen JR, Kramer D, Skylaris CK. Electrochemistry from first-principles in the grand canonical ensemble J Chem Phys. 2021 Jul 14;155(2):024114._x000D_ 8: Malgras V, Matsushita Y, Henzie J, Sugahara Y, Yamauchi Y. Free-standing membranes from the chemical exfoliation of mesoporous amorphous titania thin film Chem Commun (Camb). 2021 Jul 29;57(61):7513-7516._x000D_ 9: Dobaj Štiglic A, Lackner F, Nagaraj C, Beaumont M, Bračič M, Duarte I, Kononenko V, Drobne D, Madhan B, Finšgar M, Kargl R, Stana Kleinschek K, Mohan T. 3D-Printed Collagen-Nanocellulose Hybrid Bioscaffolds with Tailored Properties for Tissue Engineering Applications ACS Appl Bio Mater. 2023 Dec 18;6(12):5596-5608._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/38582267">10: Kumar A, Nagasaka Y, Jayananthan V, Zidan A, Heisler-Taylor T, Ambati J, Tamiya S, Kerur N. Therapeutic targeting of telomerase ameliorates experimental choroidal neovascularization Biochim Biophys Acta Mol Basis Dis. 2024 Apr 4:167156. </a>_x000D_ _x000D_ <strong>Products Related to Hybridization Neutralizing Solution can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>